Journals / European Archives of Medical Research / 2022 / Cilt: 38 - Sayı: 1

The Giant Cell Tumor of Tendon Sheath: Risk Factors for Recurrence

Pages
14–18
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presence of mitotic figures, histopathological type and tumor localization was not associated with recurrence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Giant cell tumors of tendon sheath (GCTTS) are the most common soft tissue tumors of the hand after ganglion cysts.
📊
Key Findings & Data:The recurrence rates up to 44% have been reported.
💡
Conclusion & Impact:The presence of mitotic figures, histopathological type and tumor localization was not associated with recurrence.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Giant cell tumors of tendon sheath (GCTTS) are the most common soft tissue tumors of the hand after ganglion cysts. Some other areas such as the foot, ankle, knee and thigh can also be involved. The recurrence rates up to 44% have been reported. This study evaluated the clinical results of GCTTS patients who underwent marginal resection and investigate any clinical or histopathological features that might be associated with recurrence. Methods: Thirty patients who underwent surgical excision between 2011 and 2015 were analyzed retrospectively. Clinical, pathological and radiological examination results were collected from the patient files. The variables including tumor localization, tumor subtype, bone erosion and the presence of mitotic figures were analyzed for a possible association with recurrence. Results: Amongst 30 patients who were treated surgically due to GCTTS, twenty-one patients were female (70%) and 9 were male (30%). The mean age was 40 [standard deviation (SD): ±14.4, range: 18-68 years]. The average follow-up period was 51 months (SD: ±29.2, range: 16-177 months). Histopathologically, 23 cases were identified as nodular type, 7 as diffuse type. In 8 patients, postoperative recurrence was observed. The recurrence rate was significantly higher in patients with preoperative bone erosion (p=0.015), while other variables including histopathological type, presence of mitotic figures and tumor localization did not significantly affect the recurrence rate. None of the patients experienced a malignant transformation. Conclusion: Bone erosion at the time of presentation was found to be a risk factor for recurrence in GCTTSs. The presence of mitotic figures, histopathological type and tumor localization was not associated with recurrence.

🔖

Cite This Article

KARA, M., KARAİSMAİLOĞLU, B., HIZ, M. (2022). The Giant Cell Tumor of Tendon Sheath: Risk Factors for Recurrence. European Archives of Medical Research, Cilt: 38 - Sayı: 1, 14–18. https://ajindex.com/articles/510283

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ozalp T, Yercan H, Kurt C, Ozdemir O, Coşkunol E. Giant-cell tumors of the tendon sheath involving the hand or the wrist: an analysis of 141 patients. Acta Orthop Traumatol Turc 2004;38:120-4
  2. Gouin F, Noailles T. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis). Orthop Traumatol Surg Res 2017;103:S91-7
  3. Lanzinger WD, Bindra R. Giant cell tumor of the tendon sheath. J Hand Surg Am 2013;38:154-7; quiz 157
  4. Çevik HB, Kayahan S, Eceviz E, Gümüştaş SA. Tenosynovial giant cell tumor in the hand: experience with 173 cases. J Hand Surg Asian Pac Vol 2020;25:158-63
  5. Ozben H, Coskun T. Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases. BMC Musculoskelet Disord 2019;20:457
  6. Jalgaonkar A, Dhinsa B, Cottam H, Mani G. Giant cell tumours of tendon sheath of hand: causes and strategies to prevent recurrence. Hand Surg 2011;16:149-54
  7. Koutserimpas C, Kastanis G, Ioannidis A, Filippou D, Balalis K. Giant cell tumors of the tendon sheath of the hand: an 11-year retrospective study. J BUON 2018;23:1546-51
  8. Ushijima M, Hashimoto H, Tsuneyoshi M, Enjoji M. Giant cell tumor of the tendon sheath (nodular tenosynovitis). A study of 207 cases to compare the large joint group with the common digit group. Cancer 1986;57:875-84
  9. Lautenbach M, Kim S, Millrose M, Eisenschenk A. Nodular giant cell tumour of the tendon sheath of the hand: analysis of eighty-four cases: diagnostic decisions and outcome. Int Orthop 2013;37:2211-5
  10. Al-Qattan MM. Giant cell tumours of tendon sheath: classification and recurrence rate. J Hand Surg Br 2001;26:72-5
  11. Ikeda K, Osamura N, Tomita K. Giant cell tumour in the tendon sheath of the hand: importance of the type of lesion. Scand J Plast Reconstr Surg Hand Surg 2007;41:138-42
  12. Reilly KE, Stern PJ, Dale JA. Recurrent giant cell tumors of the tendon sheath. J Hand Surg Am 1999;24:1298-302
  13. Williams J, Hodari A, Janevski P, Siddiqui A. Recurrence of giant cell tumors in the hand: a prospective study. J Hand Surg Am 2010;35:451-6
  14. Shi J, Zheng J, Zhou X, Li Z, Chen X, Gao W, et al. Risk factors associated with postoperative recurrence in patients with tenosynovial giant cell tumor of the hand: a retrospective cohort study. Ann Plast Surg 2019;83:523-8
  15. Wright CJE. Benign giant-cell synovioma: an investigation of 85 cases. Br J Surg 1951;38:257-71
  16. Rao AS, Vigor